oxcarbazepine has been researched along with Adverse Drug Event in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 5 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Assenza, G; McMurray, R; Peltola, J; Rocamora, R; Villanueva, V | 1 |
| Choi, SA; Hwang, H; Jeon, Y; Kim, H; Kim, KJ; Kim, S; Yi, S; Yoo, S | 1 |
| Kim, AH; Kim, SH; Kim, ST; Lee, JE; Min, KR | 1 |
| Alobaidly, M; Amato, MG; Bates, DW; Gammal, RS; Hasan, S; Krier, JB; Reyes, DD; Seger, DL; Shah, SN | 1 |
| Chu, K; Jang, IJ; Jang, Y; Kim, TJ; Lee, S; Lee, SK; Yoon, S; Yu, KS | 1 |
| Carleton, BC; Chantratita, W; Chen, YT; Dunnenberger, HM; Gammal, RS; George, AL; Goldspiel, B; Klein, T; Müller, DJ; Mushiroda, T; Phillips, EJ; Pirmohamed, M; Sukasem, C; Whirl-Carrillo, M | 1 |
| Liu, Y; Nie, X; Wang, X; Yu, Y; Zhao, L | 1 |
| Burns, G; Essing-Spiller, SJ; Spiller, HA; Strauch, J | 1 |
| Buggy, Y; Fogg, C; Layton, D; Shakir, SA | 1 |
| De Saint Martin, A; Fischbach, M; Fothergill, H; Gerout, AC; Laugel, V; Perville, A; Santucci, R | 1 |
| Chen, CH; Chen, YT; Chu, CY; Chung, WH; Hsih, MS; Hui, RC; Hung, SI; Liu, ZS | 1 |
| Pellock, JM; Shinnar, S | 1 |
| Haas, SJ | 1 |
1 review(s) available for oxcarbazepine and Adverse Drug Event
| Article | Year |
|---|---|
Association between HLA-B*15:02 and oxcarbazepine-induced cutaneous adverse reaction: a meta-analysis.
Topics: Carbamazepine; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Female; HLA-B15 Antigen; Humans; Male; Oxcarbazepine; Risk Factors; Skin Diseases | 2018 |
14 other study(ies) available for oxcarbazepine and Adverse Drug Event
| Article | Year |
|---|---|
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Safety, tolerability and effectiveness of transition to eslicarbazepine acetate from carbamazepine or oxcarbazepine in clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Clinical Studies as Topic; Dibenzazepines; Drug Substitution; Drug-Related Side Effects and Adverse Reactions; Europe; Female; Follow-Up Studies; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Oxcarbazepine; Young Adult | 2020 |
Analysis of antiseizure drug-related adverse reactions from the electronic health record using the common data model.
Topics: Anticonvulsants; Common Data Elements; Drug-Related Side Effects and Adverse Reactions; Electronic Health Records; Epilepsy; Humans; Lamotrigine; Levetiracetam; Oxcarbazepine; Topiramate; Valproic Acid | 2020 |
Analysis of Adverse Drug Reactions with Carbamazepine and Oxcarbazepine at a Tertiary Care Hospital.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Bipolar Disorder; Carbamazepine; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Female; Humans; Incidence; Male; Middle Aged; Neuralgia; Oxcarbazepine; Pharmacovigilance; Republic of Korea; Tertiary Care Centers; Young Adult | 2020 |
Clinical Utility of Pharmacogenomic Data Collected by a Health-System Biobank to Predict and Prevent Adverse Drug Events.
Topics: Biological Specimen Banks; Drug-Related Side Effects and Adverse Reactions; HLA-A Antigens; HLA-B Antigens; Humans; Oxcarbazepine; Pharmacogenetics; Vitamin K Epoxide Reductases; Warfarin | 2021 |
Population pharmacokinetic model development and its relationship with adverse events of oxcarbazepine in adult patients with epilepsy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Diplopia; Dizziness; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Female; Headache; Humans; Male; Middle Aged; Models, Biological; Nonlinear Dynamics; Oxcarbazepine; Seoul; Young Adult | 2021 |
Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update.
Topics: Anticonvulsants; Carbamazepine; Drug-Related Side Effects and Adverse Reactions; HLA-B Antigens; Humans; Oxcarbazepine; Pharmacogenetics | 2018 |
Thirteen years of oxcarbazepine exposures reported to US poison centers: 2000 to 2012.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Overdose; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Oxcarbazepine; Poison Control Centers; Retrospective Studies; United States; Young Adult | 2016 |
Safety profile of oxcarbazepine: results from a prescription-event monitoring study.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Carbamazepine; Child; Child, Preschool; Drug Prescriptions; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; England; Epilepsy; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Oxcarbazepine; Physicians, Family; Practice Patterns, Physicians'; Product Surveillance, Postmarketing; State Medicine; Surveys and Questionnaires | 2010 |
The onset of acute oxcarbazepine toxicity related to prescription of clarithromycin in a child with refractory epilepsy.
Topics: Carbamazepine; Child; Clarithromycin; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Humans; Oxcarbazepine | 2010 |
Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alleles; Anticonvulsants; Asian People; Carbamazepine; Case-Control Studies; Child; Drug-Related Side Effects and Adverse Reactions; Female; Genetic Association Studies; HLA Antigens; HLA-B Antigens; HLA-B15 Antigen; Humans; Lamotrigine; Male; Middle Aged; Oxcarbazepine; Pharmacogenetics; Phenytoin; Risk Factors; Stevens-Johnson Syndrome; Taiwan; Triazines; Young Adult | 2010 |
The trials and tribulations of pediatric drug trials.
Topics: Age Factors; Anticonvulsants; Brain; Carbamazepine; Child; Clinical Trials as Topic; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Humans; Monitoring, Physiologic; Oxcarbazepine; Pediatrics; Pharmacology, Clinical; Selection Bias | 2005 |
Adverse drug reaction reporting and pharmacovigilance of new therapeutic agents.
Topics: Acidosis; Adverse Drug Reaction Reporting Systems; Anticonvulsants; Carbamazepine; Communication; Cooperative Behavior; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Fructose; Humans; Hyponatremia; Topiramate | 2006 |